CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-01 | PATOU GARY Director | Grant or award · Stock Option (Right to Buy) | +3,500 | 3,500 | ||
| 2017-06-01 | TARNOW MICHAEL M Director | Grant or award · Stock Option (Right to Buy) | +3,500 | 3,500 | ||
| 2017-06-01 | TARNOW MICHAEL M Director | Grant or award · Stock Option (Right to Buy) | +1,250 | 1,250 | ||
| 2017-06-01 | Hayden Michael R Director | Grant or award · Stock Option (Right to Buy) | +3,500 | 3,500 | ||
| 2017-06-01 | HOLLER FRANK A Director | Grant or award · Stock Option (Right to Buy) | +3,500 | 3,500 | ||
| 2017-06-01 | Svoronos Dawn Director | Grant or award · Stock Option (Right to Buy) | +3,500 | 3,500 | ||
| 2017-05-12 | ROBIN SHERRINGTON SVP Bus. & Corp. Development | Exercise or conversion | +2,057 | $3.21 | $7K | 6,079 |
| 2017-05-12 | ROBIN SHERRINGTON SVP Bus. & Corp. Development | Shares withheld for taxes | −1,345 | $4.18 | $6K | 4,734 |
| 2017-05-12 | ROBIN SHERRINGTON SVP Bus. & Corp. Development | Exercise or conversion · Stock Option (Right to Buy) | −2,057 | 0 | ||
| 2017-03-14 | Hayden Michael R Director | Exercise or conversion | +18,004 | $3.70 | $67K | 115,323 |
| 2017-03-14 | Hayden Michael R Director | Exercise or conversion | +25,720 | $3.76 | $97K | 141,043 |
| 2017-03-14 | Hayden Michael R Director | Exercise or conversion | +5,144 | $3.67 | $19K | 146,187 |
| 2017-03-14 | Hayden Michael R Director | Exercise or conversion | +4,115 | $3.77 | $16K | 22,633 |
| 2017-03-14 | Hayden Michael R Director | Exercise or conversion | +4,629 | $3.07 | $14K | 27,262 |
| 2017-03-14 | Hayden Michael R Director | Exercise or conversion | +3,086 | $3.56 | $11K | 30,348 |
| 2017-03-14 | Hayden Michael R Director | Exercise or conversion · Stock Option (Right to Buy) | −18,004 | 0 | ||
| 2017-03-14 | Hayden Michael R Director | Exercise or conversion · Stock Option (Right to Buy) | −25,720 | 0 | ||
| 2017-03-14 | Hayden Michael R Director | Exercise or conversion · Stock Option (Right to Buy) | −5,144 | 0 | ||
| 2017-03-14 | Hayden Michael R Director | Exercise or conversion · Stock Option (Right to Buy) | −4,115 | 0 | ||
| 2017-03-14 | Hayden Michael R Director | Exercise or conversion · Stock Option (Right to Buy) | −4,629 | 0 |
Page 32 of 42 · 836 trades